Searched for
GSK REVENUE GOALS
GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studiesGSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achievi...- Obesity drugs gain weight in labs: Several clinical trials by big and small pharma cos underwayDriven by the success of Wegovy and Mounjaro, numerous pharma companies are developing anti-obesity drugs, with over 170 in various stages....
- HUL's growth on mute under Rohit Jawa; Priya Nair has to turn up volumeWhen Hein Schumacher's exit from Unilever signaled pressure for performance, Rohit Jawa faced the challenge of maintaining Hindustan Unilev...
- Vaccine maker Moderna forecasts lower sales next year, shares tumble 17% to near four-year lowModerna has delayed its break-even goal by two years, pushing it to 2028, due to slower regulatory processes for key products like flu and ...
- Forging a new path: ET Women Ahead shines spotlight on the most successful women in India IncThe final list of 29 – selected from an initial list of 115 female leaders from corporate India – are the names to keenly watch for in the ...
- ET 40 Under Forty: India’s brightest young business leadersThis year, as we continue the journey towards a decade, Startup India remains firmly in focus, in keeping with the country’s standing as th...
- Can Colgate withstand Patanjali’s bite?After facing a phase of uncertainty that the aggressive entry of Patanjali brought to oral care markets, established players in the space h...
- Cipla scales up offerings, investments as it eyes global lung specialty leadershipDrugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become th...
- Can ‘Bharat’ help India? The roadmap for recovery may run through India’s hinterlandCompanies had flocked to rural centres when demand was dwindling in urban areas in the initial phases of the virus outbreak. Now, with incr...
- GSK sells $3.35 billion stake in Hindustan UnileverThe 133.77 million shares were offloaded on average for 1,905 rupees, according to a statement from GlaxoSmithKline.
- Stocks in the news: HDFC Bank, Infosys, Asian paintsHere is a look at the key stocks trending in news this morning.
- More than 90% of revenues still come from acute therapy business: A Vaidheesh, GSK Pharma“The parent company feels confident that we are here to deliver.”
- Life & times of Dr Anji Reddy and his brainchild Dr Reddy'sWhen a German trader asked Reddy if he could match boots’ quality, Reddy retorted he could, by adding some impurity.
- GlaxoSmithKline Q4 profit up 66 pcGlaxoSmithKline PLC, the world's second largest drug maker by revenue, reported Thursday that its fourth-quarter profit soared by 66 percen...
- GlaxoSmithKline to axe 1,000 sales jobs in USThe world's No 2 drugmaker by revenue also will switch from having dual US headquarters to just North Carolina. Shrinking job mkt: The next...
Load More
